Daily fosfomycin versus levofloxacin for complicated urinary tract infections

Overview of attention for article published in mBio, September 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

twitter: 33 X users

Readers on

mendeley: 32 Mendeley

So far, Altmetric has seen 38 X posts from 33 X users, with an upper bound of 306,403 followers.

RT @BradSpellberg: @ABsteward @MRodgersRodgM Yup! Study link is: https://t.co/YE1MsiJxEG

@ABsteward @MRodgersRodgM Yup! Study link is: https://t.co/YE1MsiJxEG

RT @MRodgersRodgM: Another RCT from 2023 supporting oral fosfomycin in cUTI: https://t.co/wDb2ygTJBG I hadn’t heard of this study until now…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 34 additional X posts.